CHUK and hepatocellular carcinoma: These results provide new insights into the molecular mechanisms of maspin suppression in response to HBx, and revealed nuclear IKKα as a prognostic biomarker and a potential therapeutic target to improve the clinical outcome of HBV-associated HCC patients.